USANA Health Sciences USNA Proceeds from acquisition working capital adjustment

Proceeds from acquisition working capital adjustment at other companies

Enerpac Tool GroupEPAC

$0-100%

OomaOOMA

$357K+102%

Nabors IndustriesNBR

$84.43M—

Edwards LifesciencesEW

$0-100%

Corsair Gaming, Inc.CRSR

$260.25K—

Gaming and Leisure PropertiesGLPI

$0-100%

Other financials

Income statement

See full

Revenue$250.2M+0.3%

Gross profit$190.8M-3.2%

Operating income$13.9M-11.5%

Net income$7.5M-20.1%

EPS (diluted)$0.41-16.3%

Balance sheet

See full

Cash & equivalents$165.7M-9.2%

Total debt$18.0M+10.8%

Total equity$543.6M+2.6%

Total assets$739.0M-1.0%

Cash flow

See full

Operating cash flow$9.8M-37.0%

CapEx$2.6M-5.6%

Free cash flow$7.1M-43.9%

Valuation

See full

Market cap$394.19M-30.9%

P/E19.7×+8.5×

P/S0.4×-0.2×

Profitability

See full

Gross margin77.6%-3.0pp

Operating margin3.8%-2.7pp

Net margin1.9%-4.4pp

FCF margin5.7%-1.1pp

Returns & leverage

See full

Return on equity3.2%-7.6pp

Debt / equity0×0.0×

Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept usna:ProceedsFromAcquisitionOfBusinessWorkingCapitalAdjustmentsProceedsFromAcquisitionWorkingCapitalAdjustment.

The official record: USANA Health Sciences’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's proceeds from acquisition working capital adjustment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is USANA Health Sciences's proceeds from acquisition working capital adjustment?: USANA Health Sciences (USNA) reported proceeds from acquisition working capital adjustment of $216.25K in Q4 2025.
What does proceeds from acquisition working capital adjustment mean?: This represents cash received following the finalization of working capital adjustments related to a business acquisition. It indicates the recovery of value based on the difference between the estimated and actual working capital levels at the time of the transaction closing.